Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1688-1693

  Lobo, Cheryl Ann ^a   Dhar, Ravi ^a   Kumar, Nirbhay ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; MALARIA VACCINE; PARASITE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; IMMUNIZATION; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0033041978     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.4.1688-1693.1999     Document Type: Article

References (36)

1. Alano, P., and R. Carter. 1990. Sexual differentiation in malaria parasites. Ann. Rev. Microbiol. 44:429-449.
2. Bagarazzi, M., J. Boyer, V. Ayyavoo, and D. Weiner. 1998. Nucleic acid-based vaccines as an approach to immunization against the human immunodeficiency virus 1. Curr. Top. Microbiol. Immunol. 226:107-143.
3. Barr, P. J., K. M. Green, H. L. Gibson, I. C. Bathrust, I. A. Quakyi, and D. C. Kaslow. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174:1203-1208.
4. Carter, R., N. Kumar, I. Quakyi, M. F. Good, K. Mendis, P. M. Graves, and L. Miller. 1986. Immunity to sexual stages of malaria parasites. Prog. Allergy 41:193-214.
5. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M. F. Leef, M. Sedegah, L. Yuan, F. Robey, R. Beaudoin, and S. L. Hodman. 1991. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelli sporozoites. J. Immunol. 146:1020-1025.
6. Davis, H. L., M. Mancini, M. Michel, and R. Whalen. 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14:910-915.
7. Donnelly, J., J. Ulmer, J. Shiver, and M. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 16:617-648.
8. + cell, interferon gamma- and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
9. Duffy, P. E., and D. C. Kaslow. 1997. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect. Immun. 65:1109-1113.
10. Hoffman, S. L., M. Sedegah, and R. C. Hedstrom. 1994. Protection against malaria by immunization with a Plasmodium yoelli circumsporozoite protein nucleic acid vaccine. Vaccine 12:1529-1533.
11. Ifediba, T., and J. Vanderberg. 1981. Complete in vitro maturation of P. falciparum gametocytes. Nature 294:364-366.
12. Kaslow, D. C., I. Quakyi, C. Syin, M. Raum, D. Keister, J. Coligan, T. McCutchan, and L. Miller. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333:74-76.
13. Kaslow, D. C., I. Isaacs, I. Quakyi, R. Gwadz, B. Moss, and D. Keister. 1991. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science 252:1310-1313.
14. Kaslow, D. C., I. Bathurst, T. Lensen, T. Ponnudurai, P. Barr, and D. Keister. 1994. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect. Immun. 62:5576-5580.
15. Kaslow, D. C. 1993. Transmission-blocking immunity against malaria and other vector-borne diseases. Curr. Opin. Immunol. 5:557-565.
16. Kocken, C., J. Jansen, A. Kaan, P. Beckers, T. Ponnudurai, D. Kaslow, R. Konings, and J. Schoenmakers. 1993. Cloning and expression of a gene coding for transmission-blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem. Parasitol. 61:59-68.
17. Koski, G., I. Plolon, R. Viscidi, and N. Kumar. 1996. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on the 27 kDa sexual stage antigen of Plasmodium falciparum. Peptide Res. 9:127-135.
18. Kumar, N., I. Ploton, G. Koski, C. Lobo, and C. Contreras. 1995. Malaria transmission-blocking immunity - identification of epitopes and evaluation of immunogenicity. Adv. Exp. Med. Biol. 383:65-72.
19. Lobo, C. A., R. Konings, and N. Kumar. 1994. Expression of early gametocyte-stage antigens Pfg27 and Pfs16 in synchronized gametocytes and non-gametocyte producing clones of Plasmodium falciparum. Mol. Biochem. Parasitol. 68:151-154.
20. Lowrie, D. B., R. E. Tascon, M. J. Colston, and C. L. Silva. 1994. Towards a DNA vaccine against tuberculosis. Vaccine 12:1537-1540.
21. Nijhout, M. 1979. Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor. Exp. Parasitol. 48:75-80.
22. Ploton, I., B. Wizel, R. Viscidi, and N. Kumar. 1995. Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies. Vaccine 13:1161-1169.
23. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986 Antibody avidity determination by ELISA usine thiocyanate elution. J. Immunol. Methods 86:83-87.
24. Quakyi, I. A., R. Carter, J. Rener, N. Kumar, M. F. Good, and L. Miller. 1987. The 230-kD gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 139:4213-4217.
25. Rawlings, D. J., and D. C. Kaslow. 1992. A novel 40-kDa membrane-associated. EFhand calcium binding protein in Plasmodium falciparum. J. Exp. Med. 176:1483-1487.
26. Roeffen, W., F. Geeraedts, W. Eling, P. Beckers, N. Kumar, T. Lensen, and R. Sauerwein. 1995. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230 specific antibodies is isotype dependent. Infect. Immun. 63:467-471.
27. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.
28. Sedegah, M., R. Hedstrom, P. Hobart, and S. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
29. Sedegah, M., T. R. Jones, M. Kaur, R. Hedstrom, P. Hobart, J. A. Tine, and S. L. Hoffman. 1998. Boosting with recombinant vaccinia virus increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 95:7648-7653.
30. Ulmer, J., J. Donnelly, S. Parker, G. Rhodes, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
31. Vermeulen, A., T. Ponnudurai, P. Beckers, J. Verhave, M. Smits, and J. Meuwissen. 1986. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission blocking antibodies in the mosquito. J. Exp. Med. 162:1460-1476.
32. Vermeulen, A. N., J. Ven Deursen, R. H. Brakenhoff, A. H. Lensen, T. Ponnudurai, and J. H. Meuwissen. 1986. Characterization of Plasmodium falcipanum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol. Biochem. Parasitol. 20:155-163.
33. Wang, R., D. L. Doolan, P. Thong, R. C. Hedstrom, K. Coonan, Y. Charoenvit, T. Jones, P. Hobart, M. Margalith, J. Ng, W. Weiss, M. Sedegah, C. de Taisne, J. Norman, and S. L. Hoffman. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476-480.
34. Weiner, G. J., H. Liu, J. E. Woolridge, C. Dahle, and A. M. Krieg. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA 94:10833-10837.
35. Wizel, B., and N. Kumar. 1991. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity. Proc. Natl. Acad. Sci. USA 88:9533-9537.
36. Xu, U., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein gp63 of L. major. Immunology 84:173-176.